Biolase, Inc. (BIOL) Major Shareholder Larry N. Feinberg Purchases 12,545,615 Shares
Biolase, Inc. (NASDAQ:BIOL) major shareholder Larry N. Feinberg purchased 12,545,615 shares of the stock in a transaction that occurred on Tuesday, December 5th. The stock was acquired at an average cost of $0.43 per share, with a total value of $5,394,614.45. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.
Shares of Biolase, Inc. (NASDAQ:BIOL) traded up $0.03 on Wednesday, reaching $0.42. The company had a trading volume of 1,446,100 shares, compared to its average volume of 157,019. Biolase, Inc. has a 52-week low of $0.28 and a 52-week high of $1.90.
Separately, ValuEngine raised Biolase from a “sell” rating to a “hold” rating in a report on Monday, October 2nd.
Biolase Company Profile
BIOLASE, Inc (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers.
Receive News & Ratings for Biolase Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biolase Inc. and related companies with MarketBeat.com's FREE daily email newsletter.